We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 23 investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
RiskSave is an online service that makes investment easy and accessible to everyone. As RiskSave do not employ investment advisors their fees are much lower and therefore allowing the client to earn a stronger performance.
days to go: Expired investment: £272,880
Musations is a mobile application that allows you to describe your feelings through music. You can share, discover, create and discuss music with friends. Using Musations, you're able to create lip-syncs, free format music videos and voice recordings.  
days to go: Expired investment: £63
Senta assists accountants in managing and running their practices by using a cloud-based service. The software aids the accountant with marketing and CRM, scheduling tasks and deadlines, as well as providing excellent customer service and improving security. This solution eases their admin burden, which allows more time to be spent finding new businesses and increasing productivity and efficiency in their daily workflow.
days to go: Expired investment: £540,251
Virtual Reality Universe provides location based virtual and augmented reality experiences.  Expensive systems and hardware requirements put such experiences out of reach for most consumers.  Virtual Reality Universe aims are to change that by placing units in busy shopping areas and sports arenas.  (SEIS Partial)
days to go: Expired investment: £57,900
addvantage offers patented, fuel-saving technology that retrofits to heavy-duty trucks, thereby improving fuel economy, reducing harmful emissions and saving money for diesel-driven trucking fleets. Addressing two key challenges of the trucking industries--low margins and the need to reduce emissions--addvantage has a proven track record in the UK and is now launching in the US, where more than 4 million heavy duty class 8 trucks are operational. With diesel making up 40% of the trucking fleet costs in the US, the company provides compelling economics and environmental arguments for these fleets. addvantage is an exciting opportunity for investors looking for tax efficient, high growth opportunity with green credentials.
days to go: Expired investment: £394,155
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph